{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/prov/137300572"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/266390147" ] } },

    { "id" : "http://webisa.webdatacommons.org/266390147"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "In a further embodiment of the present invention, provided is a method of treating a metabolic disease or disorder, comprising administering to a patient in need of said treatment a therapeutically effective amount of a neuropeptide-2 receptor agonist of the formula (I): wherein: X is 4-oxo-6-(1-piperazinyl)-3(4H)-quinazoline-acetic acid (Pqa), Y is H, an acyl moiety, a substituted or unsubstitute" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "google.com"] } } }
